HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Meyer Selected Research

Type 2 von Willebrand Disease

4/2007von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2.
12/2004First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene.
10/2004Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.
4/2002Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
12/2001Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations.
6/2001Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.
6/2001Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology.
6/2000Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Meyer Research Topics

Disease

8Type 2 von Willebrand Disease
04/2007 - 06/2000
7von Willebrand Diseases (von Willebrand's Disease)
09/2010 - 01/2000
7Hemorrhage
05/2008 - 08/2000
7Acquired Immunodeficiency Syndrome (AIDS)
06/2006 - 03/2000
5Type 1 von Willebrand Disease
09/2010 - 04/2006
3Neoplasm Metastasis (Metastasis)
09/2020 - 05/2000
3Neoplasms (Cancer)
03/2015 - 05/2000
3Thrombotic Thrombocytopenic Purpura
03/2006 - 09/2001
2Classical Swine Fever (Swine Fever)
04/2018 - 12/2017
2Adenocarcinoma
10/2015 - 03/2015
2Necrosis
10/2015 - 01/2001
2Infections
08/2010 - 01/2009
2Thrombosis (Thrombus)
03/2004 - 02/2000
2Familial Primary Pulmonary Hypertension
07/2002 - 02/2000
2Hemolytic-Uremic Syndrome
09/2001 - 01/2001
2Hemophilia B (Haemophilia B)
09/2001 - 08/2000
2Ischemia
08/2001 - 06/2000
2Edema (Dropsy)
10/2000 - 06/2000
2Heart Failure
09/2000 - 01/2000
1Ischemic Stroke
01/2018
1Stroke (Strokes)
01/2018
1Dental Caries (Decay, Dental)
11/2013
1Osteoarthritis
08/2012
1Stomach Ulcer (Gastric Ulcer)
08/2012
1Ulcer
08/2012
1Flushing
09/2011
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
02/2011
1Pain (Aches)
11/2010
1Relapsing-Remitting Multiple Sclerosis
11/2010
1Wound Infection (Wound Infections)
08/2010
1Surgical Wound Infection
08/2010
1Tuberculosis (Tuberculoses)
01/2009
1HIV Infections (HIV Infection)
01/2009
1Crohn Disease (Crohn's Disease)
10/2008
1Fistula
10/2008
1Colorectal Neoplasms (Colorectal Cancer)
04/2008
1Type 2 Diabetes Mellitus (MODY)
12/2006
1Nocturnal Enuresis (Bedwetting)
03/2006
1Opportunistic Infections (Opportunistic Infection)
10/2005
1Venous Thromboembolism
10/2005

Drug/Important Bio-Agent (IBA)

21von Willebrand FactorIBA
09/2010 - 01/2000
8AntibodiesIBA
04/2018 - 02/2000
4Biomarkers (Surrogate Marker)IBA
09/2010 - 04/2006
3Pharmaceutical PreparationsIBA
03/2015 - 01/2009
3VaccinesIBA
10/2003 - 03/2000
2Marker VaccinesIBA
04/2018 - 12/2017
2AntigensIBA
09/2010 - 06/2001
2IronIBA
01/2009 - 01/2001
2CollagenIBA
04/2007 - 06/2001
2Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
03/2006 - 08/2000
2Factor VIII (Coagulation Factor VIII)IBA
10/2004 - 06/2001
2oxidized low density lipoproteinIBA
07/2004 - 03/2003
2HDL CholesterolIBA
07/2004 - 03/2003
2LipidsIBA
07/2004 - 03/2000
2thiamine triphosphorate (TTP)IBA
03/2004 - 09/2001
2Peptides (Polypeptides)IBA
10/2003 - 06/2002
2Proteins (Proteins, Gene)FDA Link
10/2003 - 06/2002
2Heparin (Liquaemin)FDA LinkGeneric
12/2001 - 01/2000
2ADAMTS13 ProteinIBA
09/2001 - 01/2001
2Peptide Hydrolases (Proteases)FDA Link
09/2001 - 03/2000
2Factor IX (Coagulation Factor IX)FDA LinkGeneric
09/2001 - 08/2000
2Dihydrotachysterol (AT 10)IBA
08/2001 - 06/2000
2CelsiorIBA
08/2001 - 10/2000
2Hormones (Hormone)IBA
09/2000 - 05/2000
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018
1Methanol (Carbinol)IBA
10/2015
1Auranofin (Ridaura)FDA Link
10/2015
1GoldIBA
10/2015
1Dactinomycin (Actinomycin)FDA LinkGeneric
03/2015
1Cytostatic AgentsIBA
03/2015
1Complex MixturesIBA
03/2015
1Plant ExtractsIBA
03/2015
1MercuryIBA
11/2013
1Dental AmalgamIBA
11/2013
1Acetaminophen (Paracetamol)FDA LinkGeneric
08/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2012
1ManureIBA
09/2011
1GlycosaminoglycansIBA
02/2011
1Glatiramer Acetate (Copaxone)FDA Link
11/2010
1LatexIBA
09/2010
1Deferoxamine (Desferal)FDA LinkGeneric
01/2009
1Chelating AgentsIBA
01/2009
1Cytotoxins (Cytolysins)IBA
04/2008
1Bevacizumab (Avastin)FDA Link
04/2008
1Cetuximab (Erbitux)FDA Link
04/2008
1Monoclonal AntibodiesIBA
04/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2008
1ErbB Receptors (EGF Receptor)IBA
04/2008
1Collagen Type III (Type III Collagen)IBA
04/2007
1Aryldialkylphosphatase (Paraoxonase)IBA
12/2006
1Retinaldehyde (Retinal)IBA
10/2005

Therapy/Procedure

8Therapeutics
02/2011 - 08/2000
3Highly Active Antiretroviral Therapy (HAART)
01/2009 - 08/2000
1Orchiectomy (Orchidectomy)
09/2020
1Injections
11/2010
1Perioperative Care
08/2010
1Conservative Treatment
10/2008
1Tooth Extraction (Tooth Extractions)
04/2006
1Compression Stockings
10/2005